Forge Biologics released its first Bench Strength podcast episode featuring David Dismuke and Maritza McIntyre.

Public source

Publisher name

Public post

Mass photometry is gaining traction in AAV. But where does it fit alongside AUC? Brianna Barrett, Ph.D. breaks down the role of each in empty vs. full capsid characteriz…

Log in to read the full post

Company

Forge Biologics

A member of Ajinomoto Bio-Pharma Services

Industry
Biotechnology Research
Location
Columbus, US
Company size
201–500 employees

About Forge Biologics

Forge, a member of Ajinomoto Bio-Pharma Services, is a gene therapy development engine, focused on enabling access to life changing gene therapies and helping bring them from idea into reality. We partner with innovators in the gene therapy community: scientists, physicians, biotech/pharma companies, and patient groups. We bring expertise in gene therapy manufacturing and therapeutics development to the table, helping champion teams that are navigating the long road from the lab bench to the bedside. With a patients-first approach, we are forging new models for working together to better accelerate these transformative medicines to reach those who need them most.

See more

Latest activity

6 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.